Celadon Pharmaceuticals Plc (CEL.L) Stock Price
£18.34 0.1%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
3 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Celadon Pharmaceuticals Plc, AI stock picks, stock alerts and much more.
CEL.L AI Stock Analysis
AI stock analysis for CEL.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Celadon Pharmaceuticals Plc (CEL.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Celadon Pharmaceuticals Plc (CEL.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Celadon Pharmaceuticals Plc (CEL.L), currently trading at £18.34, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CEL.L
-
Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines.
-
Symbol
CEL.L
-
Market
LSE
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
12.6M
Similar Stocks
 |
Shield Therapeutics STX.L |
£3.04 1.2% |
4 |
 |
Indivior PLC INDV.L |
£750 3% |
5 |
 |
Haleon plc HLN.L |
£383.3 1% |
6 |
 |
HUTCHMED (China) Limited HCM.L |
£220 4.3% |
5 |
 |
Hikma Pharmaceuticals PLC HIK.L |
£2288 0.2% |
6 |
News
CEL.L Alternative Data
Web Traffic
Celadon Pharmaceuticals Plc receives an estimated 679 monthly visitors to celadonpharma.co.uk.
-
Web Traffic
679
-
Change from Previous Month
3.3%
-
3 Month Change
559.2%
News Mentions
Celadon Pharmaceuticals Plc was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Celadon Pharmaceuticals Plc has 432 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.6% over the last month.
-
Twitter Followers
432
-
Daily Change
0.2%
-
1 Month Change
2.6%
-
3 Month Change
30.9%
Instagram Followers
Celadon Pharmaceuticals Plc has 39 Instagram Followers on its main Instagram account.
-
Instagram Followers
39
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
7.1%
LinkedIn Followers
2,450 are following Celadon Pharmaceuticals Plc on LinkedIn, up by 2.6% over the last month.
-
LinkedIn Followers
2450
-
Daily Change
0%
-
1 Month Change
2.6%
-
3 Month Change
5.5%
LinkedIn Employees
According to LinkedIn, Celadon Pharmaceuticals Plc has 19 employees.
-
LinkedIn Employees
19
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
5%
CEL.L Financials
CEL.L Key Metrics
-
Total Revenue
£31.5K
-
Net Income
-£1.2M
-
Earnings per Share
-£0.0185
-
Free cash flow
-£1.3M
-
EBITDA
-£1M
-
EBITDA Ratio
-32.5238
-
Total Assets
£8.5M
CEL.L 2-year Revenue & Income
CEL.L 2-year Free Cash Flow
CEL.L Technicals
CEL.L SMA
CEL.L RSI
FAQ
What's the current price of Celadon Pharmaceuticals Plc (CEL.L) Stock?
The price of an Celadon Pharmaceuticals Plc (CEL.L) share is £18.34.
What's the market cap of Celadon Pharmaceuticals Plc?
The current market cap of Celadon Pharmaceuticals Plc is 12.6M.
Should I buy or sell CEL.L?
Celadon Pharmaceuticals Plc shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Celadon Pharmaceuticals Plc is better viewed as a hold or accumulate position while waiting for further developments.
Is Celadon Pharmaceuticals Plc a good investment?
The current analysis of Celadon Pharmaceuticals Plc's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Celadon Pharmaceuticals Plc's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Celadon Pharmaceuticals Plc (CEL.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Celadon Pharmaceuticals Plc stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Celadon Pharmaceuticals Plc (CEL.L) that investors often compare it to?
Celadon Pharmaceuticals Plc (CEL.L) is often compared to similar stocks such as Shield Therapeutics, Indivior PLC, Haleon plc, HUTCHMED (China) Limited and Hikma Pharmaceuticals PLC.
What is the forecast for Celadon Pharmaceuticals Plc's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Celadon Pharmaceuticals Plc's stock price to be around £18.05 in 2026. Starting from the current price of £18.34, this represents a 1.6% change in price, indicating a neutral outlook for the stock.
How to buy Celadon Pharmaceuticals Plc (CEL.L) Stock?
Celadon Pharmaceuticals Plc stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Celadon Pharmaceuticals Plc shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.